Folates as adjuvants to anticancer agents: Chemical rationale and mechanism of action
Open Access
- 1 October 2016
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 106, 118-131
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Serine, glycine and one-carbon units: cancer metabolism in full circleNature Reviews Cancer, 2013
- Determination of reduced folates in tumor and adjacent mucosa of colorectal cancer patients using LC‐MS/MSBiomedical Chromatography, 2012
- Serine Hydroxymethyltransferase Anchors de Novo Thymidylate Synthesis Pathway to Nuclear Lamina for DNA SynthesisJournal of Biological Chemistry, 2012
- Tetrahydrofolate Recognition by the Mitochondrial Folate TransporterJournal of Biological Chemistry, 2011
- Trafficking of Intracellular FolatesAdvances in Nutrition, 2011
- CoFactor: Folate Requirement for Optimization of 5-Fluouracil Activity in Anticancer ChemotherapyJournal of Oncology, 2010
- [6S]‐5‐methyltetrahydrofolate increases plasma folate more effectively than folic acid in women with the homozygous or wild‐type 677C→T polymorphism of methylenetetrahydrofolate reductaseBritish Journal of Pharmacology, 2009
- The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intakeProceedings of the National Academy of Sciences, 2009
- SHMT1 and SHMT2 Are Functionally Redundant in Nuclear De novo Thymidylate BiosynthesisPLOS ONE, 2009
- Stereochemical mechanism of action for thymidylate synthase based on the X-ray structure of the covalent inhibitory ternary complex with 5-fluoro-2′-deoxyuridylate and 5,10-methylenetetrahydrofolateJournal of Molecular Biology, 1990